patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
daraxonrasib
Phase 3updated 2mo agoby $RVMD Revolution Medicines, Inc.
Phase 3community read0 votes
indications
indications
NSCLC
all catalysts(1)
phase 1 completion · 1
News(1)
- Revolution drug shows promise in early pancreatic cancer<p>The findings build on data suggesting Revolution’s therapy could upend treatment for a notoriously tough-to-treat tumor and generate billions in sales.</p>biopharma_dive · 2mo ago
comments(0)
5-min edit window · permanent after that